National Trends in the Use of State-Reimbursed Oral Lipid-Lowering Medications in Latvia (2012-2021)

Zinātniskās darbības rezultāts: Devums žurnālam › Konferences tēzes (žurnālā) › koleģiāli recenzēts

Oriģinālvaloda	Angļu
Žurnāls	Atherosclerosis
Sējums	379
DOIs	https://doi.org/10.1016/j.atherosclerosis.2023.06.578
Publikācijas statuss	Publicēts - 2023

OECD Zinātnes nozare

@article{47b26c8d021b47dd947c1417d44ce9d5,

title = "National Trends in the Use of State-Reimbursed Oral Lipid-Lowering Medications in Latvia (2012-2021)",

author = "Artūrs Pra{\v s}kilēvics and Inga Urtāne and Gustavs Latkovskis",

year = "2023",

doi = "10.1016/j.atherosclerosis.2023.06.578",

language = "English",

volume = "379",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - National Trends in the Use of State-Reimbursed Oral Lipid-Lowering Medications in Latvia (2012-2021)

AU - Praškilēvics, Artūrs

AU - Urtāne, Inga

AU - Latkovskis, Gustavs

PY - 2023

Y1 - 2023

UR - https://www.atherosclerosis-journal.com/article/S0021-9150(23)04670-1/fulltext

U2 - 10.1016/j.atherosclerosis.2023.06.578

DO - 10.1016/j.atherosclerosis.2023.06.578

M3 - Meeting abstract

SN - 0021-9150

VL - 379

JO - Atherosclerosis

JF - Atherosclerosis

ER -